"CONCLUSIONS
Among children and young adults with Marfan's syndrome who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aortic-root dilatation between the two treatment groups over a 3-year period. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number,NCT00429364.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1404731
No comments:
Post a Comment